Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
NEW YORK, NY–(The News File Corporation – December 27, 2024) – why: Rosen Law Firm, a global investor rights law firm, will review Dentsply Sirona Inc. (NASDAQ: XRAY ) between February 28, 2022 and November 6, 2024, both dates inclusive. (NASDAQ: XRAY ) recalls shares. Important January 27, 2025 Plaintiff’s Lead Deadline.
So what? If you purchase Dentsply Sirona common stock during the Class Period, you may receive compensation without paying any out-of-pocket fees or expenses through a contingent payment arrangement.
What to do next: To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you want to serve as lead plaintiff, you must move the court Not later than January 27, 2025. A lead plaintiff is a representative party who conducts litigation on behalf of other class members.
Why the Rose Rule? We encourage investors to select a qualified advisor with a track record of success in a leadership role. Oftentimes, the organizations that issue the ads don’t have comparable experience, resources, or any meaningful peer recognition. Most of these firms do not litigate securities class actions but are brokers who refer clients or work in partnership with law firms. Be wise when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder derivative litigation. Rosen Law Firm won the largest securities class action against a Chinese company at the time. Rosen Law Firm is rated Class 1 by ISS Securities Action (WA:) Services in 2017 for the securities division of the action settlement number. The firm has been ranked in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In the year In 2019 alone, the company raised over $438 million for investors. In the year In 2020, founding partner Lawrence Rosen was named a Titan of the Plaintiffs Bar by Law360. Many of the firm’s lawyers are accredited by Laudragon and Super Lawyers.
Details of the case:- According to the lawsuit, at class time, the defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply Sirona did not have access to good oral hygiene education for low-income individuals, a dentist, or dental insurance, which is often the case for patients; Enrollment means, a direct-to-consumer (“DTC”) alignment solution, had underlying dental problems that made them ineligible for treatment; (2) pressure for byte growth and sales commissions led sales staff to sell to restricted patients; (3) because of the above, Bayt’s patient onboarding workflow did not provide sufficient assurance that denied patients would not enter treatment; (4) reports on patient injuries before and during the episode were pouring in; (5) Densply knew that the Sirona bait lineup was causing serious patient harm for years, but did little to investigate those harms or report them to the US Food and Drug Administration (“FDA”). (6) Dentsply Sirona had no system in place to notify the FDA of these defects, which Dentsply Sirona was required to do within 30 days of discovery of a problem. (7) The FDA has found a significant increase in reports of serious injuries from bite patients. (8) As a result of the above, Densply Sirona has materially overstated the value of Byte’s goodwill. and (9) for the foregoing reason, Defendants’ positive representations about Dantsply Sirona’s business, operations and prospects are materially false and misleading and/or lack a reasonable basis at all material times. The lawsuit alleges that investors were harmed when the real listings entered the market.
To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information.
No class confirmed. Unless a unit is confirmed, you will not be represented by a consultant unless you have booked one. You can choose the advice of your choice. You can also remain a member of a class you are not in and do nothing at this point. An investor’s ability to participate in any future recovery is not dependent on serving as the lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ): https:/ /www.facebook. com/rosenlawfirm/.
Notice of attorney. Previous results do not guarantee the same result.
————————————-
To view the source of this press release, please visit https://www.newsfilecorp.com/release/235171.
